Skip to main content

Table 3 Number of patients with total VTE according to underlying specific tumor subtypes

From: Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study

 

Total VTE

No. of patients

Prevalence

Tumor type

(n = 29)

(n = 97)

(%)

High-risk group for VTE

 Stomacha

5

18

 

 Pancreasa

3

7

 

 Ovarya

1

3

 

 Lunga

2

2

 

 Urinary tracta

1

2

 

 CUPb

1

4

 

 Sarcomab

2

3

 

 Lymphomaa

0

1

 

 Total

15

40

38c

Low-risk group for VTE

 Colon or rectum

6

26

 

 Breast

5

22

 

 Esophagus

3

6

 

 Biliary tract

0

1

 

 Liver

0

1

 

 Urachus

0

1

 

 Total

14

57

25

  1. VTE venous thromboembolism, CUP cancer of unknown primary
  2. aListed as a risk factor for VTE in National Comprehensive Cancer Network Guidelines 2016 [6]. bListed as a risk factor for VTE in Asian patients [18]. cOdds ratio was 1.84 vs. low-risk group for VTE (95% confidence interval, 0.8–4.4; P = 0.25).